[Contribution of biology to the therapeutic decision: cancer of the breast in 1995].
Chinot
O
O
Laboratorie d'oncologie biologique-biopathologie tissulaire, hôpitaux de Marseille, Faculté de médecine, France.
Romain
S
S
Martin
P M
PM
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D002402:Cathepsin D / Q000032:analysis; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008875:Middle Aged; D015849:Plasminogen Inactivators; D011237:Predictive Value of Tests; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013937:Thymidine Kinase / Q000032:analysis; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis
D014408:Biomarkers, Tumor; D015849:Plasminogen Inactivators; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013937:Thymidine Kinase; D011505:Protein-Tyrosine Kinases; D014568:Urokinase-Type Plasminogen Activator; D002402:Cathepsin D